| A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer (NCT01189942) | OncoMed Pharmaceuticals, Inc. | 2010-09-01 |
| Validation of an Alternative Biological Test to Increase the Detection Sensitivity of a Colon Tumour (NCT01270360) | Assistance Publique - Hôpitaux de Paris | 2010-09-01 |
| A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy (NCT02130427) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| Re-invitation to Screening Colonoscopy: a Randomized Study (NCT01183156) | Maria Sklodowska-Curie National Research Institute of Oncology | 2010-08-01 |
| Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery (NCT01189227) | NSABP Foundation Inc | 2010-08-01 |
| Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT01190462) | Leiden University Medical Center | 2010-08-01 |
| Cytokine Changes After Colorectal Cancer Resection (NCT01244022) | University Hospital Dubrava | 2010-08-01 |
| Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer (NCT01167725) | Alliance for Clinical Trials in Oncology | 2010-08-01 |
| Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening Colonoscopy (NCT01182922) | Maria Sklodowska-Curie National Research Institute of Oncology | 2010-08-01 |
| Azacitidine and CAPOX in Metastatic Colorectal Cancer (NCT01193517) | M.D. Anderson Cancer Center | 2010-08-01 |
| Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba (NCT01026753) | University of Manitoba | 2010-08-01 |
| S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer (NCT01193452) | Fudan University | 2010-08-01 |
| Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol (NCT01196130) | M.D. Anderson Cancer Center | 2010-08-01 |
| An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer (NCT01339832) | Hoffmann-La Roche | 2010-08-01 |
| A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases (NCT01260415) | University Health Network, Toronto | 2010-08-01 |
| Increasing Colorectal and Breast Cancer Screening in Women (NCT03279198) | Indiana University | 2010-07-22 |
| QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA (NCT01147965) | NantCell, Inc. | 2010-07-16 |
| Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery (NCT01097265) | Jeroen Bosch Ziekenhuis | 2010-07-01 |
| Perfusion and Diffusion Magnetic Resonance Imaging, and Phosphorylation of Circulation Endothelial Cells to Determine Anti-anogenic Effect of Chemotherapeutic Regimens in Colorectal Liver Metastasis Patients (NCT01318239) | Yonsei University | 2010-07-01 |
| Colonic Stent and Tumor Cell Dissemination (NCT01628328) | The University of Hong Kong | 2010-07-01 |
| Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer (NCT01086267) | Bristol-Myers Squibb | 2010-07-01 |
| Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy (NCT01186263) | University of Magdeburg | 2010-07-01 |
| Impact of Probiotics in Modulation of Intestinal Microbiota (NCT01895530) | Maria Isabel Toulson Davisson Correia | 2010-07-01 |
| PET-CT and Circulating Tumor Cells in Colorectal Cancer (NCT01163305) | Chinese University of Hong Kong | 2010-06-30 |
| Survivorship in Lynch Syndrome Families (NCT01126840) | M.D. Anderson Cancer Center | 2010-06-20 |
| Colonoscope Insertion Trial Protocol (NCT01324882) | UConn Health | 2010-06-01 |
| Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective Study (NCT01186237) | Stanford University | 2010-06-01 |
| CPET in Colorectal Surgery (NCT02298907) | Liverpool University Hospitals NHS Foundation Trust | 2010-06-01 |
| Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer (NCT01139138) | The Queen Elizabeth Hospital | 2010-06-01 |
| Factors Related to Adverse Events in Colorectal Cancer (NCT02488161) | Hospital Galdakao-Usansolo | 2010-06-01 |
| Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment (NCT01380262) | Maria Sklodowska-Curie National Research Institute of Oncology | 2010-06-01 |
| Lapatinib and Cetuximab in Patients With Solid Tumors (NCT01184482) | Georgetown University | 2010-06-01 |
| Microwave Ablation for Pulmonary Metastases From Colorectal Cancer (NCT02502630) | The First People's Hospital of Changzhou | 2010-06-01 |
| General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening (NCT01364454) | Paris 12 Val de Marne University | 2010-06-01 |
| Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy (NCT01099449) | Alliance for Clinical Trials in Oncology | 2010-06-01 |
| Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery (NCT01150045) | Alliance for Clinical Trials in Oncology | 2010-06-01 |
| RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma (NCT01047293) | University of Utah | 2010-05-01 |
| Chemoprevention of Colorectal Cancer: the Role of Non-digestible Carbohydrates (NCT01214681) | Newcastle University | 2010-05-01 |
| Simultaneaous Detection of Quantitative Somatic Alterations Using the Qantitative Multiplex Pcr of Short Fluorescent Fragments Method (QMPSF) in Stage II-III Colon Cancer: a Prospective Study (NCT02110329) | University Hospital, Rouen | 2010-05-01 |
| STI.VI. Study: How to Improve Lifestyles in Screening Contexts (NCT03118882) | Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte | 2010-05-01 |
| Mutational Profiling in Colorectal Tumors to Determine Its Role in the Diagnosis, Prognostic Significance and Their Impact in Clinical Management (NCT01371942) | Taipei Medical University WanFang Hospital | 2010-05-01 |
| Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer (NCT01126112) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2010-05-01 |
| Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab (NCT01405430) | Centre Leon Berard | 2010-05-01 |
| The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas (NCT03737591) | Fudan University | 2010-05-01 |
| Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases (NCT01070355) | University of Leeds | 2010-04-01 |
| Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer (NCT01238094) | Samsung Medical Center | 2010-04-01 |
| Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec (NCT01116271) | AstraZeneca | 2010-04-01 |
| Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening (NCT01103479) | Northwestern University | 2010-04-01 |
| Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer (NCT01205711) | Cardiff University | 2010-04-01 |
| Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer (NCT01097018) | AEterna Zentaris | 2010-04-01 |
| RCT to Examine the Effects of Scanning (NCT01804621) | University of Pennsylvania | 2010-04-01 |
| Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT01110785) | Leiden University Medical Center | 2010-04-01 |
| An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Colorectal Cancer (CRONOS 1) (NCT01277120) | Hoffmann-La Roche | 2010-04-01 |
| The Inflammatory Response to Stress and Angiogenesis in Liver Resection (NCT03131778) | University Hospital, Ghent | 2010-04-01 |
| Community Engaged Colon Cancer Screening Patient Navigator Program (NCT03031171) | University of Nevada, Reno | 2010-04-01 |
| Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy (NCT01073358) | Heidelberg University | 2010-03-09 |
| FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer (NCT01133990) | Eisai Inc. | 2010-03-04 |
| Impact of Probiotics on the Intestinal Microbiota (NCT01609660) | Federal University of Minas Gerais | 2010-03-01 |
| An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL) (NCT01276405) | Hoffmann-La Roche | 2010-03-01 |
| An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS) (NCT01674907) | Hoffmann-La Roche | 2010-03-01 |
| Pilot Study of Colon Cancer Screening Tests (NCT00865527) | Hamilton Health Sciences Corporation | 2010-03-01 |
| Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery (NCT01011478) | NSABP Foundation Inc | 2010-03-01 |
| Faith Moves Mountains: A Community Based Participatory Research (CBPR) Appalachian Wellness & Cancer Prevention Program (NCT01373320) | Nancy Schoenberg | 2010-03-01 |
| Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer (NCT00952029) | Federation Francophone de Cancerologie Digestive | 2010-03-01 |
| Endoscopic Treatment of Inoperable Colorectal Cancer With the EndoVe System (NCT01172860) | Mercy University Hospital, Cork, Ireland | 2010-03-01 |
| Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor (NCT01096381) | Vanderbilt-Ingram Cancer Center | 2010-03-01 |
| Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab (NCT02029326) | Samsung Medical Center | 2010-02-01 |
| Vitamin D Levels in Stage IV Colorectal Cancer Patients (NCT01074216) | Memorial Sloan Kettering Cancer Center | 2010-02-01 |
| Changes in Stem Cells of the Colon in Response to Increased Risk of Colorectal Cancer (NCT01075893) | Newcastle University | 2010-02-01 |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy (NCT01164215) | UNC Lineberger Comprehensive Cancer Center | 2010-02-01 |
| TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer (NCT01060423) | Hans-Joachim Schmoll, MD | 2010-02-01 |
| Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer (NCT01071655) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2010-02-01 |
| Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer (NCT00940316) | Northwestern University | 2010-01-18 |
| Risk Factors for Residual Neoplasia After Endoscopic Mucosal Resection (NCT01478919) | Vitkovice Hospital | 2010-01-01 |
| Increasing Colorectal Cancer Screening Uptake With a Patient Navigator (NCT01506687) | Cancer Care Ontario | 2010-01-01 |
| Treatment Strategies for Primarily Generalized Colorectal Cancer (NCT01056809) | Vrinnevi Hospital | 2010-01-01 |
| Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (NCT01086618) | University College London Hospitals | 2010-01-01 |
| Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases (NCT02419677) | The First People's Hospital of Changzhou | 2010-01-01 |
| First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras (NCT01057017) | Brown University | 2010-01-01 |
| Compression Anastomosis For Low Anterior Resection in Previously Radiated Patients Using the CAR™ 27 (NCT01056796) | Niti Medical Technologies Ltd. | 2010-01-01 |
| Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART) (NCT01089413) | Hoffmann-La Roche | 2010-01-01 |
| Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery. (NCT00874224) | Maastricht University Medical Center | 2010-01-01 |
| A Reversal in the Vascularity of Metastatic Liver Tumors From Colorectal Cancer After the Cessation of Anti-VEGF Therapy (NCT01591109) | NHO - Matsumoto Medical Center | 2010-01-01 |
| Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer (NCT01064375) | Maria Liljefors | 2009-12-01 |
| Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor (NCT01048463) | Sun Yat-sen University | 2009-12-01 |
| KRAS Wild-type Metastatic Colorectal Cancer Trial (NCT00879385) | University of Utah | 2009-12-01 |
| OSI-906 and Irinotecan in Patients With Advanced Cancer (NCT01016860) | University of Colorado, Denver | 2009-12-01 |
| A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer (NCT01032291) | Celgene Corporation | 2009-12-01 |
| Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy? (NCT01035775) | Indiana University | 2009-12-01 |
| PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study (NCT00911170) | Amgen | 2009-11-03 |
| Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer (NCT01243372) | Alliance for Clinical Trials in Oncology | 2009-11-01 |
| Chemotherapy-Induced Peripheral Neuropathy Survey (NCT01016028) | M.D. Anderson Cancer Center | 2009-11-01 |
| Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC) (NCT00997685) | Guangdong Provincial People's Hospital | 2009-11-01 |
| Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer (NCT00966667) | Rutgers, The State University of New Jersey | 2009-11-01 |
| A Comparison of Methods to Detect Polyps During Colonoscopy (NCT01025960) | The Cleveland Clinic | 2009-11-01 |
| Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy (NCT00911391) | University of Auckland, New Zealand | 2009-11-01 |
| Processed Meat and Colon Carcinogenesis (NCT00994526) | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement | 2009-10-01 |
| A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675) (NCT01047475) | Microbio Co Ltd | 2009-10-01 |
| J-Pouch Colorectal Anastomosis or Straight Colorectal Anastomosis in Treating Patients With Rectal Cancer Who Have Undergone Surgery to Remove the Tumor (NCT01110798) | Azienda Ospedaliera di Padova | 2009-10-01 |
| Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors (NCT00908024) | Bristol-Myers Squibb | 2009-10-01 |